KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Eli Lilly (LLY) Operating Expenses (2016 - 2025)

Historic Operating Expenses for Eli Lilly (LLY) over the last 17 years, with Q3 2025 value amounting to $6.6 billion.

  • Eli Lilly's Operating Expenses rose 3368.53% to $6.6 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $23.7 billion, marking a year-over-year increase of 2332.19%. This contributed to the annual value of $20.4 billion for FY2024, which is 2181.1% up from last year.
  • According to the latest figures from Q3 2025, Eli Lilly's Operating Expenses is $6.6 billion, which was up 3368.53% from $6.1 billion recorded in Q2 2025.
  • Eli Lilly's Operating Expenses' 5-year high stood at $6.6 billion during Q3 2025, with a 5-year trough of $3.2 billion in Q1 2022.
  • For the 5-year period, Eli Lilly's Operating Expenses averaged around $4.4 billion, with its median value being $4.2 billion (2023).
  • Its Operating Expenses has fluctuated over the past 5 years, first plummeted by 843.14% in 2022, then surged by 3368.53% in 2025.
  • Quarter analysis of 5 years shows Eli Lilly's Operating Expenses stood at $3.6 billion in 2021, then increased by 2.29% to $3.7 billion in 2022, then grew by 23.87% to $4.6 billion in 2023, then grew by 27.14% to $5.8 billion in 2024, then increased by 13.47% to $6.6 billion in 2025.
  • Its Operating Expenses stands at $6.6 billion for Q3 2025, versus $6.1 billion for Q2 2025 and $5.2 billion for Q1 2025.